235 filings
6-K
GLMD
Galmed Pharmaceuticals Ltd
19 Mar 24
Current report (foreign)
4:30pm
6-K
GLMD
Galmed Pharmaceuticals Ltd
15 Mar 24
Current report (foreign)
9:13am
EFFECT
GLMD
Galmed Pharmaceuticals Ltd
30 Nov 23
Notice of effectiveness
12:15am
POS AM
GLMD
Galmed Pharmaceuticals Ltd
22 Nov 23
Prospectus update (post-effective amendment)
4:48pm
6-K
lht0 izmtp4b42yj
22 Nov 23
Current report (foreign)
4:05pm
6-K
a5pq enwh
20 Nov 23
Galmed Announces a delay in the initiation of its Primary Sclerosing Cholangitis (PSC) Phase 2a Study
4:37pm
POS AM
13xk7jdvhv5t
1 Nov 23
Prospectus update (post-effective amendment)
4:15pm
6-K
uswudm41p6
26 Sep 23
Galmed Announces Allowance of New Patent for Aramchol for the Treatment of Pulmonary and Dermal Fibrosis
8:51am
6-K
46qw8v6
22 Sep 23
Galmed Pharmaceuticals Announces Receipt of Nasdaq Minimum Bid Price Notification
4:15pm
6-K/A
1magwuwow347 z5
21 Sep 23
Current report (foreign) (amended)
7:30am
6-K
fae75u4 tczvvjd95w0q
20 Sep 23
Current report (foreign)
4:30pm
6-K
s2bf5epszfw601j6qof
13 Sep 23
Current report (foreign)
4:01pm
6-K
b1h715
9 Aug 23
Current report (foreign)
4:43pm
6-K
zl9q2l
9 Aug 23
Current report (foreign)
4:30pm
6-K
gnlf94dovykgl2d4cn
2 Aug 23
Consolidated Financial Statements
4:30pm
6-K
aaepup1z u21o2r
18 Jul 23
Current report (foreign)
9:25am
424B4
sod9cm5vg edh2435mko
18 Jul 23
Prospectus supplement with pricing info
9:23am
EFFECT
zc7srojcip49 qf
17 Jul 23
Notice of effectiveness
12:15am
6-K
epoupj5 1hzo2
14 Jul 23
Galmed Pharmaceuticals Announces Pricing of $7 Million Public Offering
9:44am